{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:08Z","timestamp":1789689608217,"version":"4.0.1"},"update-to":[{"DOI":"10.1016\/j.ijbiomac.2025.142558","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000}}],"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ijbiomac.2025.142558","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T19:09:11Z","timestamp":1743188951000},"page":"142558","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"P2","title":["RETRACTED:\u00a0pH-responsive mesoporous silica nanoparticles functionalized with folic acid and chitosan for targeted epirubicin delivery: In vitro and in vivo efficacy in breast cancer"],"prefix":"10.1016","volume":"309","author":[{"given":"Nasim Kaveh","family":"Farsani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamim","family":"Afshari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita Saremi","family":"Poor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvin","family":"Toutounchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Shahbazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Ramezani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadreza","family":"Tajik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoumeh Mirzaei","family":"Chegeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nastaran Asghari","family":"Moghaddam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Abbasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ijbiomac.2025.142558_bb0005","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.31557\/APJCP.2019.20.7.2015","article-title":"Global trend of breast cancer mortality rate: a 25-year study","volume":"20","author":"Azamjah","year":"2019","journal-title":"Asian Pacific J. Cancer Prev.: APJCP"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.142558_bb0010","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S0360-3016(02)04201-3","article-title":"Ten-year outcome after combined modality therapy for inflammatory breast cancer","volume":"55","author":"Harris","year":"2003","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.142558_bb0015","doi-asserted-by":"crossref","first-page":"138","DOI":"10.25100\/cm.v48i3.2997","article-title":"Immunotherapy and gene therapy as novel treatments for cancer","volume":"48","author":"Rangel-Sosa","year":"2017","journal-title":"Colomb. Med."},{"key":"10.1016\/j.ijbiomac.2025.142558_bb0020","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jcis.2023.02.041","article-title":"Degradable iron-rich mesoporous dopamine as a dual-glutathione depletion nanoplatform for photothermal-enhanced ferroptosis and chemodynamic therapy","volume":"639","author":"Cheng","year":"2023","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ijbiomac.2025.142558_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114643","article-title":"Overcoming Cancer Multi-drug Resistance (MDR): reasons, mechanisms, nanotherapeutic solutions, and challenges","volume":"162","author":"Duan","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijbiomac.2025.142558_bb0030","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2165\/00003495-199753030-00008","article-title":"Epirubicin: an updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of breast cancer","volume":"53","author":"Coukell","year":"1997","journal-title":"Drugs"},{"key":"10.1016\/j.ijbiomac.2025.142558_bb0035","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ejpb.2014.12.009","article-title":"Surface functionalized mesoporous silica nanoparticles as an effective carrier for epirubicin delivery to cancer cells","volume":"89","author":"Hanafi-Bojd","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.142558_bb0040","article-title":"The effect of mesoporous silica nanoparticles loaded with epirubicin on drug-resistant cancer cells","volume":"4","author":"Hanafi-Bojd","year":"2017","journal-title":"Nanomed. J."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.142558_bb0045","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.breast.2011.12.012","article-title":"Epirubicin: is it like doxorubicin in breast cancer? A clinical review","volume":"21","author":"Khasraw","year":"2012","journal-title":"Breast"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.142558_bb0050","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2025.142558_bb0055","first-page":"10","article-title":"Nanoparticle-based drug delivery systems for cancer therapy","volume":"1","author":"Dang","year":"2020","journal-title":"Smart Mater. Med."},{"issue":"02","key":"10.1016\/j.ijbiomac.2025.142558_bb0060","doi-asserted-by":"crossref","DOI":"10.4172\/2329-6631.1000174","article-title":"Mesoporous silica nanoparticles: a review","volume":"6","author":"Mehmood","year":"2017","journal-title":"J. Dev. Drugs"},{"key":"10.1016\/j.ijbiomac.2025.142558_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2023.148270","article-title":"Nanozyme-mediated biocatalysis as a mitochondrial oxidative stress amplifier for tumor nanocatalytic immunotherapy","volume":"481","author":"Lu","year":"2024","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.ijbiomac.2025.142558_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.111526","article-title":"Biodegradable nanocarriers based on chitosan-modified mesoporous silica nanoparticles for delivery of methotrexate for application in breast cancer treatment","volume":"118","author":"Shakeran","year":"2021","journal-title":"Mater. Sci. Eng. C"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.142558_bb0075","doi-asserted-by":"crossref","DOI":"10.1002\/mabi.202000034","article-title":"An adjustable ph-responsive drug delivery system based on self-assembly polypeptide-modified mesoporous silica","volume":"20","author":"Yang","year":"2020","journal-title":"Macromol. Biosci."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.142558_bb0080","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3390\/pharmaceutics11090430","article-title":"Folic acid and PEI modified mesoporous silica for targeted delivery of curcumin","volume":"11","author":"Sun","year":"2019","journal-title":"Pharmaceutics"},{"issue":"107","key":"10.1016\/j.ijbiomac.2025.142558_bb0085","doi-asserted-by":"crossref","first-page":"105578","DOI":"10.1039\/C6RA23182A","article-title":"Chitosan-folate coated mesoporous silica nanoparticles as a smart and pH-sensitive system for curcumin delivery","volume":"6","author":"Daryasari","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.ijbiomac.2025.142558_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfa.2020.124470","article-title":"A pH-sensitive drug delivery system based on folic acid-targeted HBP-modified mesoporous silica nanoparticles for cancer therapy","volume":"590","author":"Li","year":"2020","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"issue":"44","key":"10.1016\/j.ijbiomac.2025.142558_bb0095","doi-asserted-by":"crossref","first-page":"6147","DOI":"10.1039\/c3tb20867b","article-title":"Preparation, characterization, and in vitro evaluation of folate-modified mesoporous bioactive glass for targeted anticancer drug carriers","volume":"1","author":"Lin","year":"2013","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.ijbiomac.2025.142558_bb0100","doi-asserted-by":"crossref","first-page":"7315","DOI":"10.2147\/OTT.S113815","article-title":"Mesoporous silica nanoparticles functionalized with folic acid\/methionine for active targeted delivery of docetaxel","author":"Khosravian","year":"2016","journal-title":"Onco. Targets. Ther."},{"key":"10.1016\/j.ijbiomac.2025.142558_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2021.112289","article-title":"The other side to the use of active targeting ligands; the case of folic acid in the targeting of breast cancer","volume":"211","author":"Helmy","year":"2022","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.ijbiomac.2025.142558_bb0110","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.ijbiomac.2018.09.058","article-title":"A self-targeting and controllable drug delivery system constituting mesoporous silica nanoparticles fabricated with a multi-stimuli responsive chitosan-based thin film layer","volume":"122","author":"Chen","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2025.142558_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.134362","article-title":"In-vitro and in-vivo evaluation of angiogenic potential of a novel lithium chloride loaded silk fibroin\/alginate 3D porous scaffold with antibacterial activity, for promoting diabetic wound healing","volume":"277","author":"Bashiri","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2025.142558_bb0120","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jiec.2024.04.013","article-title":"Exploring the effects of nano-liposomal TGF-\u03b21 on induced pluripotent stem cell-derived vascular smooth muscle cells in tissue-engineered vascular graft; an in vivo study","volume":"138","author":"Jafarkhani","year":"2024","journal-title":"J. Ind. Eng. Chem."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2025.142558_bb0125","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijpharm.2017.09.066","article-title":"Dual targeting mesoporous silica nanoparticles for inhibiting tumour cell invasion and metastasis","volume":"534","author":"Li","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"30","key":"10.1016\/j.ijbiomac.2025.142558_bb0130","doi-asserted-by":"crossref","first-page":"7711","DOI":"10.1016\/j.biomaterials.2011.06.066","article-title":"A pH-responsive mesoporous silica nanoparticles-based multi-drug delivery system for overcoming multi-drug resistance","volume":"32","author":"He","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijbiomac.2025.142558_bb0135","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.2147\/IJN.S363952","article-title":"Functionalized mesoporous silica nanoparticles for drug-delivery to multidrug-resistant cancer cells","author":"Igaz","year":"2022","journal-title":"Int. J. Nanomedicine"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.142558_bb0140","first-page":"220","article-title":"Application of mesoporous silica nanoparticles for drug delivery to cancer cells","volume":"27","author":"Malaekeh-Nikouei","year":"2020","journal-title":"J. Birjand Univ. Med. Sci."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.142558_bb0145","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1039\/C8NJ05476B","article-title":"Folate-targeting and bovine serum albumin-gated mesoporous silica nanoparticles as a redox-responsive carrier for epirubicin release","volume":"43","author":"Zhang","year":"2019","journal-title":"New J. Chem."},{"key":"10.1016\/j.ijbiomac.2025.142558_bb0150","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s10971-015-3844-8","article-title":"Mesoporous silica materials functionalized with folic acid: preparation, characterization and release profile study with methotrexate","volume":"77","author":"Freitas","year":"2016","journal-title":"J. Sol-Gel Sci. Technol."},{"issue":"26","key":"10.1016\/j.ijbiomac.2025.142558_bb0155","doi-asserted-by":"crossref","first-page":"7482","DOI":"10.1039\/c1cc12259b","article-title":"Mesoporous MFI zeolites by microwave induced assembly between sulfonic acid functionalized MFI zeolite nanoparticles and alkyltrimethylammonium cationic surfactants","volume":"47","author":"Jin","year":"2011","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ijbiomac.2025.142558_bb0160","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.colsurfa.2015.11.031","article-title":"Fabrication of folic acid functionalized pH-responsive and thermosensitive magnetic chitosan microcapsules via a simple sonochemical method","volume":"490","author":"Xu","year":"2016","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.142558_bb0165","first-page":"34","article-title":"pH-responsive mesoporous silica nanoparticles employed in controlled drug delivery systems for cancer treatment","volume":"11","author":"Yang","year":"2014","journal-title":"Cancer Biol. Med."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.142558_bb0170","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3390\/pharmaceutics15020447","article-title":"Natural biopolymers as smart coating materials of mesoporous silica nanoparticles for drug delivery","volume":"15","author":"Dumontel","year":"2023","journal-title":"Pharmaceutics"},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.142558_bb0175","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.3390\/molecules26103031","article-title":"Nanoformulation development to improve the biopharmaceutical properties of fisetin using design of experiment approach","volume":"26","author":"Liu","year":"2021","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.142558_bb0180","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3390\/nano11020273","article-title":"Roles of chitosan in green synthesis of metal nanoparticles for biomedical applications","volume":"11","author":"Phan","year":"2021","journal-title":"Nanomaterials"},{"key":"10.1016\/j.ijbiomac.2025.142558_bb0185","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s12645-010-0006-0","article-title":"Evaluation of cytotoxicity and mechanism of apoptosis of doxorubicin using folate-decorated chitosan nanoparticles for targeted delivery to retinoblastoma","volume":"1","author":"Parveen","year":"2010","journal-title":"Cancer Nanotechnol."},{"key":"10.1016\/j.ijbiomac.2025.142558_bb0190","series-title":"Seminars in Hematology","first-page":"179","article-title":"Flow cytometry in analysis of cell cycle and apoptosis","author":"Darzynkiewicz","year":"2001"},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2025.142558_bb0195","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0022-1759(00)00233-7","article-title":"Flow cytometry of apoptotic cell death","volume":"243","author":"Vermes","year":"2000","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ijbiomac.2025.142558_bb0200","series-title":"Apoptosis and Cancer: Methods and Protocols","first-page":"137","article-title":"Caspase activity assays","author":"Niles","year":"2008"},{"issue":"46","key":"10.1016\/j.ijbiomac.2025.142558_bb0205","doi-asserted-by":"crossref","first-page":"6183","DOI":"10.1038\/sj.onc.1203043","article-title":"Bis, a Bcl-2-binding protein that synergizes with Bcl-2 in preventing cell death","volume":"18","author":"Lee","year":"1999","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.142558_bb0210","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nrc883","article-title":"The Bcl2 family: regulators of the cellular life-or-death switch","volume":"2","author":"Cory","year":"2002","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.142558_bb0215","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrm2308","article-title":"The BCL-2 protein family: opposing activities that mediate cell death","volume":"9","author":"Youle","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ijbiomac.2025.142558_bb0220","first-page":"88","article-title":"A review on cell cycle checkpoints in relation to cancer","volume":"5","author":"Panda","year":"2019","journal-title":"J. Med. Sci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.142558_bb0225","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ab.2004.12.026","article-title":"Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay","volume":"338","author":"Parker","year":"2005","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ijbiomac.2025.142558_bb0230","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1023\/B:PHAM.0000016249.52831.a5","article-title":"Uptake and cytotoxicity of chitosan molecules and nanoparticles: effects of molecular weight and degree of deacetylation","volume":"21","author":"Huang","year":"2004","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.142558_bb0235","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.3390\/md13031133","article-title":"Chitin and chitosan preparation from marine sources. Structure, properties and applications","volume":"13","author":"Younes","year":"2015","journal-title":"Mar. Drugs"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.142558_bb0240","first-page":"157","article-title":"A prognostic study of MDA, SOD and catalase in breast cancer patients","volume":"4","author":"Sahu","year":"2015","journal-title":"Int. J. Sci. Res."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.142558_bb0245","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.3390\/molecules28073228","article-title":"Therapeutic potential of albumin nanoparticles encapsulated Visnagin in MDA-MB-468 triple-negative breast cancer cells","volume":"28","author":"Alsrhani","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2025.142558_bb0250","article-title":"Reactive-oxygen-species-scavenging nanomaterials for resolving inflammation","volume":"11","author":"Huang","year":"2021","journal-title":"Mater. Today Bio"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.142558_bb0255","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1084\/jem.20110367","article-title":"Mitochondrial reactive oxygen species drive proinflammatory cytokine production","volume":"208","author":"Naik","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ijbiomac.2025.142558_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107525","article-title":"Role of the ERO1-PDI interaction in oxidative protein folding and disease","volume":"210","author":"Shergalis","year":"2020","journal-title":"Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.142558_bb0265","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.tem.2017.02.008","article-title":"Nutrient sensing and the oxidative stress response","volume":"28","author":"Luo","year":"2017","journal-title":"Trends Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.142558_bb0270","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.drup.2004.01.004","article-title":"ROS stress in cancer cells and therapeutic implications","volume":"7","author":"Pelicano","year":"2004","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.ijbiomac.2025.142558_bb0275","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.18520\/cs\/v113\/i08\/1530-1542","article-title":"Folic acid decorated chitosan nanoparticles and its derivatives for the delivery of drugs and genes to cancer cells","author":"John","year":"2017","journal-title":"Curr. Sci."},{"issue":"15","key":"10.1016\/j.ijbiomac.2025.142558_bb0280","doi-asserted-by":"crossref","first-page":"8041","DOI":"10.3390\/ijms25158041","article-title":"Histochemistry for molecular imaging in nanomedicine","volume":"25","author":"Malatesta","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.142558_bb0285","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/BF02897257","article-title":"Hepatic tissue distribution of doxorubicin-loaded nanoparticles after iv administration in reticulosarcoma M 5076 metastasis-bearing mice","volume":"26","author":"Chiannilkulchai","year":"1990","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.142558_bb0290","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1111\/cbdd.13309","article-title":"A comparison of mesoporous silica nanoparticles and mesoporous organosilica nanoparticles as drug vehicles for cancer therapy","volume":"92","author":"Yue","year":"2018","journal-title":"Chem. Biol. Drug Des."},{"issue":"12_Supplement","key":"10.1016\/j.ijbiomac.2025.142558_bb0295","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2022-2458","article-title":"Comparing influences of active targeting and nanoparticle size on tumor specificity in pancreatic adenocarcinoma","volume":"82","author":"MacCuaig","year":"2022","journal-title":"Cancer Res."},{"issue":"sup2","key":"10.1016\/j.ijbiomac.2025.142558_bb0300","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1080\/21691401.2018.1464461","article-title":"Improved anticancer efficacy of epirubicin by magnetic mesoporous silica nanoparticles: in vitro and in vivo studies","volume":"46","author":"Ansari","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."}],"updated-by":[{"DOI":"10.1016\/j.ijbiomac.2025.142558","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000}},{"DOI":"10.1016\/j.ijbiomac.2026.152741","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000}},{"DOI":"10.1016\/j.ijbiomac.2026.152741","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000}},{"DOI":"10.1016\/j.ijbiomac.2026.152741","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"record-id":"72467"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025031101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025031101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T10:46:05Z","timestamp":1782902765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025031101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":60,"alternative-id":["S0141813025031101"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.142558","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RETRACTED:\u00a0pH-responsive mesoporous silica nanoparticles functionalized with folic acid and chitosan for targeted epirubicin delivery: In vitro and in vivo efficacy in breast cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.142558","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"142558"}}